
Ly D. Pham
Examiner (ID: 13044, Phone: (571)272-1793 , Office: P/2827 )
| Most Active Art Unit | 2827 |
| Art Unit(s) | 2713, 2827, 2818 |
| Total Applications | 2188 |
| Issued Applications | 2041 |
| Pending Applications | 77 |
| Abandoned Applications | 106 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18512550
[patent_doc_number] => 20230228755
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-20
[patent_title] => METHODS OF DIAGNOSING AND TREATING LUNG CANCER
[patent_app_type] => utility
[patent_app_number] => 18/102088
[patent_app_country] => US
[patent_app_date] => 2023-01-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10904
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 212
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18102088
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/102088 | Methods of diagnosing and treating lung cancer | Jan 26, 2023 | Issued |
Array
(
[id] => 18538746
[patent_doc_number] => 20230243852
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => METHODS AND COMPOSITIONS FOR DIFFERENTIATING PROGRESSIVE CHRONIC KIDNEY DISEASE FROM STABLE CHRONIC KIDNEY DISEASE
[patent_app_type] => utility
[patent_app_number] => 18/160000
[patent_app_country] => US
[patent_app_date] => 2023-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18719
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18160000
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/160000 | METHODS AND COMPOSITIONS FOR DIFFERENTIATING PROGRESSIVE CHRONIC KIDNEY DISEASE FROM STABLE CHRONIC KIDNEY DISEASE | Jan 25, 2023 | Pending |
Array
(
[id] => 18676790
[patent_doc_number] => 20230314420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-05
[patent_title] => ASSAYS FOR FIXED DOSE COMBINATIONS
[patent_app_type] => utility
[patent_app_number] => 18/153234
[patent_app_country] => US
[patent_app_date] => 2023-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38578
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18153234
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/153234 | ASSAYS FOR FIXED DOSE COMBINATIONS | Jan 10, 2023 | Pending |
Array
(
[id] => 18693986
[patent_doc_number] => 20230324389
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-12
[patent_title] => COMPOSITIONS AND METHODS RELATED TO ACTIVATABLE THERAPEUTIC AGENTS
[patent_app_type] => utility
[patent_app_number] => 18/068872
[patent_app_country] => US
[patent_app_date] => 2022-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 105596
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18068872
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/068872 | COMPOSITIONS AND METHODS RELATED TO ACTIVATABLE THERAPEUTIC AGENTS | Dec 19, 2022 | Pending |
Array
(
[id] => 18486186
[patent_doc_number] => 20230213529
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-06
[patent_title] => Detection and Quantification of AKT-mTOR Pathway Proteins
[patent_app_type] => utility
[patent_app_number] => 18/068047
[patent_app_country] => US
[patent_app_date] => 2022-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11873
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18068047
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/068047 | Detection and quantification of AKT-mTOR pathway proteins | Dec 18, 2022 | Issued |
Array
(
[id] => 18312630
[patent_doc_number] => 20230116530
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => METHOD FOR DETECTING NUCLEOSOMES CONTAINING HISTONE VARIANTS
[patent_app_type] => utility
[patent_app_number] => 18/076005
[patent_app_country] => US
[patent_app_date] => 2022-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17652
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18076005
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/076005 | METHOD FOR DETECTING NUCLEOSOMES CONTAINING HISTONE VARIANTS | Dec 5, 2022 | Abandoned |
Array
(
[id] => 18956587
[patent_doc_number] => 20240044914
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure
[patent_app_type] => utility
[patent_app_number] => 18/049490
[patent_app_country] => US
[patent_app_date] => 2022-10-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 77810
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18049490
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/049490 | Methods and Compositions for Diagnosis and Prognosis of Renal Injury and Renal Failure | Oct 24, 2022 | Abandoned |
Array
(
[id] => 18192336
[patent_doc_number] => 20230045855
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => DIAGNOSIS OF AUTOIMMUNE DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/936729
[patent_app_country] => US
[patent_app_date] => 2022-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20439
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17936729
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/936729 | Diagnosis of autoimmune disease | Sep 28, 2022 | Issued |
Array
(
[id] => 19227763
[patent_doc_number] => 12007397
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-11
[patent_title] => Enhanced detection and quantitation of biomolecules
[patent_app_type] => utility
[patent_app_number] => 17/931469
[patent_app_country] => US
[patent_app_date] => 2022-09-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 21086
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17931469
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/931469 | Enhanced detection and quantitation of biomolecules | Sep 11, 2022 | Issued |
Array
(
[id] => 18240477
[patent_doc_number] => 20230072788
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => Uses of 5-Aminovaleric Acid Betaine and Compositions Related Thereto
[patent_app_type] => utility
[patent_app_number] => 17/903392
[patent_app_country] => US
[patent_app_date] => 2022-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6850
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 20
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17903392
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/903392 | Uses of 5-Aminovaleric Acid Betaine and Compositions Related Thereto | Sep 5, 2022 | Abandoned |
Array
(
[id] => 18241670
[patent_doc_number] => 20230073981
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => METHODS FOR THE ASSESSMENT OF RISK AND TREATMENTS FOR LIVER CANCERS AND LETHAL LIVER DISEASE COMPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/896944
[patent_app_country] => US
[patent_app_date] => 2022-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24184
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17896944
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/896944 | Methods for the assessment of risk and treatments for liver cancers and lethal liver disease complications | Aug 25, 2022 | Issued |
Array
(
[id] => 19044693
[patent_doc_number] => 11933792
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-19
[patent_title] => Markers for renal disease
[patent_app_type] => utility
[patent_app_number] => 17/815765
[patent_app_country] => US
[patent_app_date] => 2022-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 15790
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17815765
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/815765 | Markers for renal disease | Jul 27, 2022 | Issued |
Array
(
[id] => 18251613
[patent_doc_number] => 20230078652
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => METHODS FOR PREDICTION OF ANTI-TNF ALPHA DRUG LEVELS AND AUTOANTIBODY FORMATION
[patent_app_type] => utility
[patent_app_number] => 17/815016
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17601
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17815016
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/815016 | METHODS FOR PREDICTION OF ANTI-TNF ALPHA DRUG LEVELS AND AUTOANTIBODY FORMATION | Jul 25, 2022 | Abandoned |
Array
(
[id] => 18021045
[patent_doc_number] => 20220372544
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => METHODS FOR DIAGNOSING AND TREATING INFLAMMATORY BOWEL DISEASE
[patent_app_type] => utility
[patent_app_number] => 17/872674
[patent_app_country] => US
[patent_app_date] => 2022-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26976
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17872674
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/872674 | Methods for diagnosing and treating inflammatory bowel disease | Jul 24, 2022 | Issued |
Array
(
[id] => 19121919
[patent_doc_number] => 11965893
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-04-23
[patent_title] => Biomarker for preeclampsia
[patent_app_type] => utility
[patent_app_number] => 17/811167
[patent_app_country] => US
[patent_app_date] => 2022-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 6
[patent_no_of_words] => 8698
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17811167
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/811167 | Biomarker for preeclampsia | Jul 6, 2022 | Issued |
Array
(
[id] => 18037558
[patent_doc_number] => 20220381774
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => MULTIPLEXED BEAD ARRAYS FOR PROTEOMICS
[patent_app_type] => utility
[patent_app_number] => 17/838666
[patent_app_country] => US
[patent_app_date] => 2022-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23334
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17838666
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/838666 | MULTIPLEXED BEAD ARRAYS FOR PROTEOMICS | Jun 12, 2022 | Abandoned |
Array
(
[id] => 19537742
[patent_doc_number] => 12130293
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-29
[patent_title] => Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers
[patent_app_type] => utility
[patent_app_number] => 17/746341
[patent_app_country] => US
[patent_app_date] => 2022-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 4
[patent_no_of_words] => 10838
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 174
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17746341
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/746341 | Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers | May 16, 2022 | Issued |
Array
(
[id] => 18997112
[patent_doc_number] => 11913948
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Method for accurate diagnosis of a disease targeting biomarkers in liquid biopsy
[patent_app_type] => utility
[patent_app_number] => 17/663670
[patent_app_country] => US
[patent_app_date] => 2022-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 2
[patent_no_of_words] => 7727
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 217
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17663670
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/663670 | Method for accurate diagnosis of a disease targeting biomarkers in liquid biopsy | May 16, 2022 | Issued |
Array
(
[id] => 19677094
[patent_doc_number] => 12188948
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-07
[patent_title] => Metabolite biomarkers for diseases associated with the contact activation system
[patent_app_type] => utility
[patent_app_number] => 17/728285
[patent_app_country] => US
[patent_app_date] => 2022-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 2
[patent_no_of_words] => 15800
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17728285
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/728285 | Metabolite biomarkers for diseases associated with the contact activation system | Apr 24, 2022 | Issued |
Array
(
[id] => 19211789
[patent_doc_number] => 12000845
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-06-04
[patent_title] => Method for discharging a patient from an intensive care unit
[patent_app_type] => utility
[patent_app_number] => 17/710369
[patent_app_country] => US
[patent_app_date] => 2022-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40252
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 88
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17710369
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/710369 | Method for discharging a patient from an intensive care unit | Mar 30, 2022 | Issued |